Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclosporine vs Infliximab in Steroid-refractory UC
NCT00542152Phase 4Completed
- Sponsor
- GETAID
- Start
- Jun 2007
- Primary completion
- Jun 2007
- Modality
- Monoclonal Antibodies
- Countries
- 5
01
Overview
A Phase 4 trial of infliximab in ulcerative colitis (UC), sponsored by GETAID. Started Jun 2007; status: completed.
02
Drugs
infliximab
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT00542152.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00542152.